Allogene Therapeutics Inc (ALLO)
2.11
+0.06
(+2.93%)
USD |
NASDAQ |
Nov 21, 16:00
2.11
0.00 (0.00%)
After-Hours: 20:00
Allogene Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -295.5K% |
| December 31, 2023 | -408.5K% |
| September 30, 2023 | -283.1K% |
| June 30, 2023 | -360.1K% |
| March 31, 2023 | -333.2K% |
| December 31, 2022 | |
| September 30, 2022 | -169.7K% |
| Date | Value |
|---|---|
| June 30, 2022 | -86.96K% |
| March 31, 2022 | -130.9K% |
| December 31, 2021 | 0.11% |
| September 30, 2021 | -159.6K% |
| June 30, 2021 | -161.2K% |
| March 31, 2021 | -86.10% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-408.5K%
Minimum
Dec 2023
0.11%
Maximum
Dec 2021
-199.1K%
Average
-165.5K%
Median
Profit Margin (Quarterly) Benchmarks
| ANI Pharmaceuticals Inc | -16.29% |
| AIM ImmunoTech Inc | -10.57K% |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 18.02% |
| Armata Pharmaceuticals Inc | -- |